NEUROONE MEDICAL TECHNOLOGIE (NMTC) Stock Price, Quote, News and Overview
NASDAQ:NMTC - Nasdaq - US64130M2098 - Common Stock - Currency: USD
NMTC Quote, Performance and Key Statistics
1.15
+0.03 (+2.68%)
The current stock price of NMTC is 1.15 USD. In the past month the price increased by 2.68%. In the past year, price increased by 7.48%.
NMTC Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About NMTC
Company Profile
NeuroOne Medical Technologies Corp. is a medical technology company, which engages in the development and commercialization of thin film electrode technology for continuous electroencephalogram and stereoelectrocencephalography recording, spinal cord stimulation, brain stimulation, and ablation solutions. The company is headquartered in Eden Prairie, Minnesota and currently employs 16 full-time employees. The company went IPO on 2012-11-09. The firm is focused on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, spinal cord stimulation, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. The company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure and artificial intelligence. Its Evo cortical electrode technology records, monitors, and stimulates brain tissue on the surface of the brain. Its products include strip/grid, depth electrodes (sEEG Products) and electrode cable assembly products.
Company Info
NEUROONE MEDICAL TECHNOLOGIE
7599 Anagram Dr
Eden Prairie MINNESOTA US
Employees: 16
Company Website: https://nmtc1.com/
Investor Relations: http://www.n1mtc.com/investors
Phone: 19524261383
NEUROONE MEDICAL TECHNOLOGIE / NMTC FAQ
What is the stock price of NEUROONE MEDICAL TECHNOLOGIE today?
The current stock price of NMTC is 1.15 USD. The price increased by 2.68% in the last trading session.
What is the ticker symbol for NEUROONE MEDICAL TECHNOLOGIE stock?
The exchange symbol of NEUROONE MEDICAL TECHNOLOGIE is NMTC and it is listed on the Nasdaq exchange.
On which exchange is NMTC stock listed?
NMTC stock is listed on the Nasdaq exchange.
What is NEUROONE MEDICAL TECHNOLOGIE worth?
NEUROONE MEDICAL TECHNOLOGIE (NMTC) has a market capitalization of 35.49M USD. This makes NMTC a Nano Cap stock.
How many employees does NEUROONE MEDICAL TECHNOLOGIE have?
NEUROONE MEDICAL TECHNOLOGIE (NMTC) currently has 16 employees.
What are the support and resistance levels for NEUROONE MEDICAL TECHNOLOGIE (NMTC) stock?
NEUROONE MEDICAL TECHNOLOGIE (NMTC) has a support level at 1.14 and a resistance level at 1.21. Check the full technical report for a detailed analysis of NMTC support and resistance levels.
Is NEUROONE MEDICAL TECHNOLOGIE (NMTC) expected to grow?
The Revenue of NEUROONE MEDICAL TECHNOLOGIE (NMTC) is expected to grow by 90% in the next year. Check the estimates tab for more information on the NMTC EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NEUROONE MEDICAL TECHNOLOGIE (NMTC) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NMTC, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NMTC, evaluating the profitability, health, valuation and growth aspects
- NEUROONE MEDICAL TECHNOLOGIE (NMTC) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NEUROONE MEDICAL TECHNOLOGIE (NMTC) Sales and EPS estimates to see what analysts future expectations are.
- NEUROONE MEDICAL TECHNOLOGIE (NMTC) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NEUROONE MEDICAL TECHNOLOGIE (NMTC) Insider and Institutional Ownership to learn about the owners and their transactions.
- NEUROONE MEDICAL TECHNOLOGIE (NMTC) Stock Chart to make your own analysis
- NEUROONE MEDICAL TECHNOLOGIE (NMTC) Latest news and press-releases to stay up to date.
Does NEUROONE MEDICAL TECHNOLOGIE (NMTC) stock pay dividends?
NMTC does not pay a dividend.
When does NEUROONE MEDICAL TECHNOLOGIE (NMTC) report earnings?
NEUROONE MEDICAL TECHNOLOGIE (NMTC) will report earnings on 2025-05-12, after the market close.
What is the Price/Earnings (PE) ratio of NEUROONE MEDICAL TECHNOLOGIE (NMTC)?
NEUROONE MEDICAL TECHNOLOGIE (NMTC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.27).
What is the Short Interest ratio of NEUROONE MEDICAL TECHNOLOGIE (NMTC) stock?
The outstanding short interest for NEUROONE MEDICAL TECHNOLOGIE (NMTC) is 0.57% of its float. Check the ownership tab for more information on the NMTC short interest.
NMTC Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to NMTC. When comparing the yearly performance of all stocks, NMTC is one of the better performing stocks in the market, outperforming 92.49% of all stocks.
NMTC Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NMTC. NMTC has a bad profitability rating. Also its financial health evaluation is rather negative.
NMTC Financial Highlights
Over the last trailing twelve months NMTC reported a non-GAAP Earnings per Share(EPS) of -0.27. The EPS increased by 61.47% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -110.68% | ||
| ROE | -244.88% | ||
| Debt/Equity | 0.6 |
NMTC Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to NMTC. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 33.33% and a revenue growth 90% for NMTC